Delivery Order SPE2DX22D0010-SPE2D826FAB94
Award Date 10/3/25
Potential Completion Date 10/6/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $9,654.96 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 36MG, a pharmaceutical product. This firm fixed price delivery order, issued on July 14, 2025, represents a child contract under a larger indefinite delivery vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award was competitively awarded...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for 36mg Xtampza ER capsules valued at $6,176.76 on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for the federal military healthcare system. The vendor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,341.70 to AmerisourceBergen Drug Corp for the supply of Xtampza ER 13.5 mg capsules (100 count) on August 18, 2025, with completion targeted for August 19, 2025. The award is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Xtampza ER 18 mg capsules (100-count units) with a ceiling value of $5,707.86. This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made without a...
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count packages) valued at $6,281.84 under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Xtampza ER 13.5 mg capsules (100-count units) with a ceiling value of $2,302.80. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The ultimate completion date is July 23, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.69 to AmerisourceBergen Drug Corp for Xtampza ER 36 mg capsules (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pain management pharmaceutical supply for military and federal healthcare systems. The contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...